PROVIDER PROFILE · NPI 1528294790
John KuryanM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,113
Unique beneficiaries
—
Total services
17,278
Distinct HCPCS
16
Medicare payment
$259K
Peer benchmark
Total Medicare services vs. 142 Allergy/ Immunology providers in PA — top quintile (cohort median 2,860).
PRESCRIBING · PART D · 2024
Total Rx claims
1,233
Beneficiaries
—
Total drug cost
$464K
Distinct drugs
23
Brand share
48.3%
Top prescribed drugs
Montelukast Sodium184 claims
Fluticasone/Umeclidin/Vilanter179 claims
Fluticasone Propionate151 claims
Albuterol Sulfate135 claims
Ipratropium Bromide93 claims
QUALITY · MIPS · 2024
Final MIPS score
51.1
Quality
63.8
Cost
85.3
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-2.87%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$7K
Payment records
48
By payment type
Consulting Fee$5K
Food and Beverage$1K
Travel and Lodging$316
Top paying entities
Consulting Fee$5K
Food and Beverage$1K
Travel and Lodging$316
REFERRAL NETWORK
Where John Kuryan's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Steven Smith Allergy/ Immunology · Philadelphia, PA | 36 | 112 |
| Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Norristown, PA | 26 | 51 |
| Norman Koven Allergy/ Immunology · Richboro, PA | 19 | 58 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ | 18 | 52 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE